“Driving the Future of Cancer care,” an evening presented by the Institute for Value-Based medicine and The American Journal of Managed Care took place in Boston on July 17. It …
Tag:
CAR T-cell therapy
-
-
About a third of patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL) who are treated with chimeric antigen receptor (CAR) T-cell therapy see their disease progress, according to …